Clinical Trial Update: Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating androgen deprivation therapy added to radiotherapy for oligo-recurrent prostate cancer; current status is active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Androgen deprivation therapy (ADT) (Androgen deprivation therapy)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Prostate Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING